nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Ibuprofen—Melphalan—peripheral nervous system neoplasm	0.708	1	CrCrCtD
Esmolol—Chlorphenesin—BCHE—peripheral nervous system neoplasm	0.00171	0.383	CrCbGaD
Esmolol—Atenolol—ABCB1—peripheral nervous system neoplasm	0.000668	0.15	CrCbGaD
Esmolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.000617	0.138	CrCbGaD
Esmolol—Metoprolol—ABCB1—peripheral nervous system neoplasm	0.000521	0.117	CrCbGaD
Esmolol—Propafenone—ABCB1—peripheral nervous system neoplasm	0.000384	0.0861	CrCbGaD
Esmolol—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.00121	CcSEcCtD
Esmolol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000348	0.00121	CcSEcCtD
Esmolol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000348	0.00121	CcSEcCtD
Esmolol—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00121	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.0012	CcSEcCtD
Esmolol—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000345	0.0012	CcSEcCtD
Esmolol—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00119	CcSEcCtD
Esmolol—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000343	0.00119	CcSEcCtD
Esmolol—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00119	CcSEcCtD
Esmolol—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000341	0.00119	CcSEcCtD
Esmolol—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.00118	CcSEcCtD
Esmolol—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00034	0.00118	CcSEcCtD
Esmolol—Flushing—Etoposide—peripheral nervous system neoplasm	0.00034	0.00118	CcSEcCtD
Esmolol—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.00117	CcSEcCtD
Esmolol—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.00117	CcSEcCtD
Esmolol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00116	CcSEcCtD
Esmolol—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000333	0.00116	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00115	CcSEcCtD
Esmolol—Chills—Etoposide—peripheral nervous system neoplasm	0.000329	0.00114	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.00114	CcSEcCtD
Esmolol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.00114	CcSEcCtD
Esmolol—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00114	CcSEcCtD
Esmolol—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00114	CcSEcCtD
Esmolol—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00113	CcSEcCtD
Esmolol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00112	CcSEcCtD
Esmolol—Oedema—Vincristine—peripheral nervous system neoplasm	0.000322	0.00112	CcSEcCtD
Esmolol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000319	0.00111	CcSEcCtD
Esmolol—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.00111	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.0011	CcSEcCtD
Esmolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000316	0.0011	CcSEcCtD
Esmolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000316	0.0011	CcSEcCtD
Esmolol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000315	0.0011	CcSEcCtD
Esmolol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000314	0.00109	CcSEcCtD
Esmolol—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000313	0.00109	CcSEcCtD
Esmolol—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000313	0.00109	CcSEcCtD
Esmolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000312	0.00108	CcSEcCtD
Esmolol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00108	CcSEcCtD
Esmolol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000312	0.00108	CcSEcCtD
Esmolol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000312	0.00108	CcSEcCtD
Esmolol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000311	0.00108	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00108	CcSEcCtD
Esmolol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00031	0.00108	CcSEcCtD
Esmolol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000308	0.00107	CcSEcCtD
Esmolol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000308	0.00107	CcSEcCtD
Esmolol—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000307	0.00107	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00106	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.00105	CcSEcCtD
Esmolol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000302	0.00105	CcSEcCtD
Esmolol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000301	0.00104	CcSEcCtD
Esmolol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00104	CcSEcCtD
Esmolol—Ibuprofen—ABCB1—peripheral nervous system neoplasm	0.000298	0.067	CrCbGaD
Esmolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00103	CcSEcCtD
Esmolol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00103	CcSEcCtD
Esmolol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000297	0.00103	CcSEcCtD
Esmolol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000296	0.00103	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000295	0.00102	CcSEcCtD
Esmolol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.00102	CcSEcCtD
Esmolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000294	0.00102	CcSEcCtD
Esmolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000291	0.00101	CcSEcCtD
Esmolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000291	0.00101	CcSEcCtD
Esmolol—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00101	CcSEcCtD
Esmolol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000289	0.001	CcSEcCtD
Esmolol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.001	CcSEcCtD
Esmolol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.001	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.001	CcSEcCtD
Esmolol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.000992	CcSEcCtD
Esmolol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.000992	CcSEcCtD
Esmolol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.000989	CcSEcCtD
Esmolol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000284	0.000989	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000982	CcSEcCtD
Esmolol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000282	0.000981	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000979	CcSEcCtD
Esmolol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000281	0.000975	CcSEcCtD
Esmolol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00028	0.000974	CcSEcCtD
Esmolol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00028	0.000974	CcSEcCtD
Esmolol—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00028	0.000972	CcSEcCtD
Esmolol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000279	0.00097	CcSEcCtD
Esmolol—Headache—Topotecan—peripheral nervous system neoplasm	0.000278	0.000967	CcSEcCtD
Esmolol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000278	0.000965	CcSEcCtD
Esmolol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000277	0.000964	CcSEcCtD
Esmolol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000277	0.000962	CcSEcCtD
Esmolol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000276	0.000961	CcSEcCtD
Esmolol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000276	0.00096	CcSEcCtD
Esmolol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000276	0.000959	CcSEcCtD
Esmolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000276	0.000959	CcSEcCtD
Esmolol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.000956	CcSEcCtD
Esmolol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000275	0.000956	CcSEcCtD
Esmolol—Pain—Vincristine—peripheral nervous system neoplasm	0.000275	0.000956	CcSEcCtD
Esmolol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000275	0.000956	CcSEcCtD
Esmolol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000272	0.000945	CcSEcCtD
Esmolol—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000271	0.000942	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00027	0.000938	CcSEcCtD
Esmolol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000924	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000924	CcSEcCtD
Esmolol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000922	CcSEcCtD
Esmolol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.000917	CcSEcCtD
Esmolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000264	0.000917	CcSEcCtD
Esmolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000263	0.059	CrCbGaD
Esmolol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000263	0.000913	CcSEcCtD
Esmolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000262	0.000909	CcSEcCtD
Esmolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000262	0.000909	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000909	CcSEcCtD
Esmolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.000898	CcSEcCtD
Esmolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000258	0.000898	CcSEcCtD
Esmolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000255	0.000888	CcSEcCtD
Esmolol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000254	0.000884	CcSEcCtD
Esmolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000254	0.000881	CcSEcCtD
Esmolol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000253	0.00088	CcSEcCtD
Esmolol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000252	0.000876	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00087	CcSEcCtD
Esmolol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000248	0.000863	CcSEcCtD
Esmolol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000859	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000855	CcSEcCtD
Esmolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000854	CcSEcCtD
Esmolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000243	0.000846	CcSEcCtD
Esmolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000243	0.000845	CcSEcCtD
Esmolol—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000835	CcSEcCtD
Esmolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.000833	CcSEcCtD
Esmolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.000821	CcSEcCtD
Esmolol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000234	0.000815	CcSEcCtD
Esmolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000234	0.000813	CcSEcCtD
Esmolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000232	0.000808	CcSEcCtD
Esmolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000232	0.000805	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000805	CcSEcCtD
Esmolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000231	0.000802	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000796	CcSEcCtD
Esmolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000229	0.000796	CcSEcCtD
Esmolol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000227	0.000787	CcSEcCtD
Esmolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000225	0.000782	CcSEcCtD
Esmolol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000225	0.000782	CcSEcCtD
Esmolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000225	0.000781	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00078	CcSEcCtD
Esmolol—Pain—Etoposide—peripheral nervous system neoplasm	0.000223	0.000775	CcSEcCtD
Esmolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000223	0.000775	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000772	CcSEcCtD
Esmolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.000767	CcSEcCtD
Esmolol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000215	0.000746	CcSEcCtD
Esmolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.000743	CcSEcCtD
Esmolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000213	0.000739	CcSEcCtD
Esmolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.000738	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000737	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000728	CcSEcCtD
Esmolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.000727	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000722	CcSEcCtD
Esmolol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000207	0.00072	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000716	CcSEcCtD
Esmolol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000206	0.000716	CcSEcCtD
Esmolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000205	0.000711	CcSEcCtD
Esmolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000709	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000709	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000706	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000701	CcSEcCtD
Esmolol—Headache—Vincristine—peripheral nervous system neoplasm	0.000202	0.0007	CcSEcCtD
Esmolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.000689	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000689	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000673	CcSEcCtD
Esmolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000191	0.000664	CcSEcCtD
Esmolol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000663	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000663	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000663	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000656	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000653	CcSEcCtD
Esmolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000187	0.00065	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000648	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000648	CcSEcCtD
Esmolol—Chills—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000641	CcSEcCtD
Esmolol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000184	0.000641	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000637	CcSEcCtD
Esmolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000629	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000626	CcSEcCtD
Esmolol—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000622	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000614	CcSEcCtD
Esmolol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000614	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000609	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.0006	CcSEcCtD
Esmolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000172	0.000599	CcSEcCtD
Esmolol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000593	CcSEcCtD
Esmolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000587	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000579	CcSEcCtD
Esmolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000166	0.000576	CcSEcCtD
Esmolol—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000576	CcSEcCtD
Esmolol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000572	CcSEcCtD
Esmolol—Headache—Etoposide—peripheral nervous system neoplasm	0.000163	0.000567	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000564	CcSEcCtD
Esmolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000558	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000547	CcSEcCtD
Esmolol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000539	CcSEcCtD
Esmolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000155	0.000538	CcSEcCtD
Esmolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00053	CcSEcCtD
Esmolol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000529	CcSEcCtD
Esmolol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000528	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000526	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000518	CcSEcCtD
Esmolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000516	CcSEcCtD
Esmolol—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000512	CcSEcCtD
Esmolol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000508	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000506	CcSEcCtD
Esmolol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000144	0.0005	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000499	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000498	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000493	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000491	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00049	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000488	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000487	CcSEcCtD
Esmolol—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000484	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000479	CcSEcCtD
Esmolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000474	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000474	CcSEcCtD
Esmolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00047	CcSEcCtD
Esmolol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000462	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000461	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000456	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000456	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000454	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000453	CcSEcCtD
Esmolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000451	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000448	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000447	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000441	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000439	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000438	CcSEcCtD
Esmolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000438	CcSEcCtD
Esmolol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000434	CcSEcCtD
Esmolol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000434	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000422	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000419	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000418	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000418	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000414	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000408	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000406	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000405	CcSEcCtD
Esmolol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000403	CcSEcCtD
Esmolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000402	CcSEcCtD
Esmolol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000402	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000401	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000387	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000373	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000371	CcSEcCtD
Esmolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000364	CcSEcCtD
Esmolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000359	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000337	CcSEcCtD
Esmolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000336	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000332	CcSEcCtD
Esmolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.000323	CcSEcCtD
Esmolol—Headache—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000318	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000311	CcSEcCtD
Esmolol—Nausea—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000302	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000299	CcSEcCtD
Esmolol—Headache—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000294	CcSEcCtD
Esmolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000279	CcSEcCtD
